Ready, Set, GYO!
Chemotherapy: PARP-inhibitors, Bevacizumab, and Ovarian Cytotoxics
29:32
In this episode, we discuss antineoplastic agents for ovarian cancer. We discuss PARP-inhibitors, homologous recombination deficiency, bevacizumab, as well as new cytotoxic chemotherapy used in the treatment of ovarian cancers.
Join us for bi-weekly episodes or check out our episode archive and show notes at readysetgyo.com. Follow us on Instagram @ReadySetGYOPod. Find us on Twitter and support…